Sheridan Ross P.C. names four new shareholders

Sheridan Ross announced today that it has named four new shareholders in the firm, effective Aug. 18.

The new shareholders are James Burke, Hiwot Covell, Patricia Ho and David Kellis. Burke and Covell were firm associates while Ho and Kellis served as Of Counsel.

Burke’s experience and client counsel includes all areas of patent prosecution ranging from portfolio protection strategies and patentability analysis to drafting applications and freedom to operate opinions. His work spans across a wide range of mechanical arts including medical and drug delivery devices, packaging technology, manufacturing and assembly methods, outdoor and recreation gear, bicycle components, structural components, and tooling and hardware.

Covell’s practice focuses on patent litigation and patent prosecution for chemical, biological and mechanical processes and devices. Her experience includes preparing and prosecuting domestic and international patent applications, preparing patent validity, patentability and freedom-to-operate opinions, and drafting licensing agreements. Covell also works with clients to enforce their intellectual property rights in federal courts and her experience includes work at every stage of litigation from drafting motions and depositions to oral arguments.

Ho’s practice focuses on patent, trademark and other intellectual property litigation and counseling. She has represented clients in a variety of intellectual property cases in state and federal courts, as well as in front of administrative bodies. Her experience includes managing all aspects of litigation in cases addressing issues of patent and trademark infringement, copyright infringement, false advertising, unfair competition, and trade secrets. In addition, she has counseled clients on licensing, and patent and trademark prosecution as well as handling matters before the Trademark Trial and Appeal Board.

Kellis counsels clients in intellectual property matters, with a focus on developing and implementing sound intellectual property strategies. He helps clients obtain domestic and international patent rights, drafts technology-related agreements, and prepares patent validity, patent infringement, and freedom to operate opinions. In counseling his clients, Kellis draws upon his experience with all phases of litigation, which includes arguing motions and participating in jury and bench trials across the country. His practice has included work in the areas of access control, aerospace, clean energy, consumer electronics, displays, LIDAR, medical devices, power machinery, RFID, software, textiles, vehicles and vehicle wheels, among others.

The use of sedative/hypnotic drugs, such as Ambien, can lead to the formation of physical and/or mental dependence. Dependence may also occur when using therapeutic doses and/or in patients without individual risk factors. The risk of addiction increases with an increase in the dose of the drug and the duration of treatment, it is also higher in patients with a history of mental disorders, alcohol abuse, or other drugs and non-medicinal substances. Such patients should be under particularly close supervision when taking sleeping pills. Read more at https://asahiramen.com/ambien-for-sale/.